comparemela.com

Latest Breaking News On - Cell signaling - Page 2 : comparemela.com

The CRL5–SPSB3 ubiquitin ligase targets nuclear cGAS for degradation

Cyclic GMP-AMP synthase (cGAS) senses aberrant DNA during infection, cancer and inflammatory disease, and initiates potent innate immune responses through the synthesis of 2′3′-cyclic GMP-AMP (cGAMP)1–7. The indiscriminate activity of cGAS towards DNA demands tight regulatory mechanisms that are necessary to maintain cell and tissue homeostasis under normal conditions. Inside the cell nucleus, anchoring to nucleosomes and competition with chromatin architectural proteins jointly prohibit cGAS activation by genomic DNA8–15. However, the fate of nuclear cGAS and its role in cell physiology remains unclear. Here we show that the ubiquitin proteasomal system (UPS) degrades nuclear cGAS in cycling cells. We identify SPSB3 as the cGAS-targeting substrate receptor that associates with the cullin–RING ubiquitin ligase 5 (CRL5) complex to ligate ubiquitin onto nuclear cGAS. A cryo-electron microscopy structure of nucleosome-bound cGAS in a complex

Signs of a Hormone Imbalance and Products to Help

Erika from Natural Healthy Concepts in Appleton joins Living with Amy to talk about what types of things hormones control in our bodies.

Beaver Dam Road, Cell Signaling Technologies projects moving ahead

UNE to receive $10 8 million in funding for disease development research

UNE to receive $10 8 million in funding for disease development research
fox23maine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fox23maine.com Daily Mail and Mail on Sunday newspapers.

UNE gets $10 8M award to launch research center, explore role of cell signals in disease

UNE gets $10 8M award to launch research center, explore role of cell signals in disease
mainebiz.biz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mainebiz.biz Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.